TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Mar 31, 2021 14:09 JST
Source:
Toyota Motor Corporation
Toyota: First Refrigerated Vehicle for Vaccine in the World to Obtain WHO's Performance, Quality and Safety Prequalification
Establishing methods for refrigerated vaccine transportation and contributing toward improving the rate of vaccine use in developing countries
Toyota City, Japan, Mar 31, 2021 - (JCN Newswire) - Toyota Tsusho Corporation, Toyota Motor Corporation, and B Medical Systems S.a r.l. announced today that the vehicle with a dedicated refrigerator for transporting vaccines at the appropriate temperatures developed jointly by the three companies has obtained Performance, Quality and Safety (PQS) prequalification for quality of medical devices and equipment as set by the World Health Organization (WHO). The company registered for the prequalification is Toyota Tsusho and this is the first refrigerated vehicle for vaccines in the world that has obtained PQS prequalification.
1. Background
Vaccination is an effective measure against infectious diseases. General mandatory vaccines for infants usually require storage at 2 to 8degC, and cannot be used if not stored under proper temperature management. Although developing countries receive assistance from international agencies such as GAVI, the Vaccine Alliance and UNICEF for the supply of vaccines, approximately 20% of the volume supplied (equivalent to JPY 40 billion per year) are disposed annually because they become unusable due to temperature changes during transportation when distributing to hospitals and clinics within the respective countries, as the road infrastructures are inadequate and there is no proper means for refrigerated transportation. Each year, the lives of 1.5 million children are lost to vaccine preventable diseases (VPD) with insufficient effective utilization of vaccines being one of the reasons.
2. WHO's PQS and Significance of Prequalification
PQS is a system for the qualification of medical devices and equipment by WHO that was established to promote the development of medical devices and equipment applicable for the United Nations' procurement as well as to set quality standards. Medical devices and equipment which have obtained PQS prequalification also meet the equipment selection standards of agencies related to the United Nations and leading NGOs and charity organizations.
Also, it is easier for developing countries without their own qualification system for medical devices and equipment to receive support for transportation equipment procurement by using PQS as the qualification standard, and effective use of vaccines can be expected.
This initiative contributes to the effective use of vaccines, addressing a social issue in developing countries. At the same time, it has the significance of being able to demonstrate initiative in the field of global health transportation. In addition, this refrigerated vehicle for vaccines can now be used under the international framework COVAX, which seeks to distribute vaccines for COVID-19 fairly to developing countries, and its use as a means of transportation for COVID-19 vaccines can also be expected.
3. Overview of Refrigerated Vehicle for Vaccines
The features of the refrigerated vehicle for vaccines which obtained PQS prequalification this time are as follows:
- The base vehicle is Toyota Land Cruiser 78, which is equipped with the B Medical Systems' CF850 vaccine refrigerator.
- The refrigerator has a storage capacity of 396 liters, or 400 vaccine packages.
- With its independent battery, the refrigerator can be operated for approximately 16 hours without a power supply.
- The refrigerator can be charged by the vehicle while driving and from an external power source when parked.
4. Roles of Each Company
1. Toyota Tsusho uses the knowledge and awareness of issues developed through business in Africa to provide the refrigerated vehicle for vaccines as the company obtaining PQS prequalification.
2. Toyota provides the Toyota Land Cruiser 78.
3. B Medical Systems provides the CF850 vaccine refrigerator.
4. Toyota Tsusho Group company CFAO SAS and Toyota Group company TOYOTA CUSTOMIZING & DEVELOPMENT Co., Ltd. conduct vehicle installation and conversion.
"We aim to deliver Safety and Security".
For this project, Toyota Tsusho, Toyota, and B-Medical Systems, have joined forces with the same goal in mind. We will continue to make efforts so that the obtainment of PQS for the refrigerated vehicle for vaccines will contribute to the Safety and Security of the region.
Source: Toyota Motor Corporation
Sectors: Automotive, Motorsports
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
Acropolis Rally Greece: Day 4 Sunday success and second overall for TOYOTA GAZOO Racing's Ogier
June 30 2025 19:15 JST
Mitsubishi Fuso-Hino Merger: 4 Firms Collaborate for the Future of Commercial Vehicles
June 30 2025 19:10 JST
Implementation of Measures to Enhance Our Corporate Value in Connection with Toyota Industries Corporation
June 03 2025 18:54 JST
Toyota Group to Accelerate Collaboration Towards Transforming into a Mobility Company Through Privatization of Toyota Industries Corporation
June 03 2025 18:16 JST
Construction Begins on New Toyota Tokyo Head Office in Shinagawa, to Open in FY2030
May 27 2025 13:31 JST
Five Toyota Group Companies to Accelerate Skill Development and Innovation in AI and Software
May 23 2025 09:51 JST
New RAV4 Makes World Premiere in Japan
May 21 2025 13:09 JST
Premiere of New bZ Woodland BEV Focused on Driving Performance and Spaciousness in North America
May 16 2025 15:35 JST
TOYOTA GAZOO Racing fights back for double points finish
May 12 2025 14:45 JST
TOYOTA GAZOO Racing Set for Spa spectacle
May 02 2025 18:29 JST
More Press release >>
Latest Press Release
JCB and Mandai Wildlife Group Deepen Partnership with exclusive discounts for JCB cardmembers
Jul 01, 2025 16:00 JST
Fujitsu provides Japan's first AI-powered cloud-based library search service
Jul 01, 2025 11:30 JST
JCB Brings Apple Pay to Cardmembers in Vietnam
Jul 01, 2025 11:15 JST
First Shipment of LNG from the LNG Canada Project
Jul 01, 2025 11:00 JST
Approval in Principle (AiP) for World's First LCO2 / Methanol Carrier
Jun 30, 2025 20:30 JST
Acropolis Rally Greece: Day 4 Sunday success and second overall for TOYOTA GAZOO Racing's Ogier
Jun 30, 2025 20:15 JST
Mitsubishi Fuso-Hino Merger: 4 Firms Collaborate for the Future of Commercial Vehicles
Jun 30, 2025 20:10 JST
Six Companies Establish BlueRebirth Council to Expand Use of Recycled Materials in New Vehicles
Jun 30, 2025 19:25 JST
Honda Changes Plan to Build New Production Plant for Next-generation Fuel Cell Module in Japan
Jun 30, 2025 19:20 JST
MHI-AC&R Receives Recommendation Award of JARAC's 42nd Excellent Energy Saving Equipment Awards
Jun 30, 2025 19:00 JST
The University of Osaka and Fujitsu Japan launch joint research on AI-powered education support for culturally and linguistically diverse children in Japan
Jun 30, 2025 12:00 JST
JCB has launched contactless subway payment services in Shanghai and Beijing, marking the first such service in mainland China
Jun 30, 2025 12:00 JST
Honda Opens "Honda Software Studio Osaka" as New Software Development Operation
Jun 26, 2025 13:30 JST
Honda Issues "Honda ESG Report 2025"
Jun 26, 2025 13:29 JST
Fujitsu's Uvance Wayfinders consulting empowers customers to evolve business foundations leveraging data and AI
Jun 26, 2025 11:00 JST
MHI Receives Contract for Refurbishment of APM System at Singapore Changi Airport
Jun 25, 2025 14:00 JST
Special Summer Event "Tanabata Festival at Anime Tokyo Station" Feature a Public Recording of a Chat and Dramatic Reading by Voice Actors Miina Tominaga and Wataru Takagi on July 7
Jun 25, 2025 11:00 JST
Technica Zen and BSI Professional Services Japan Launch Customizable Training to Strengthen AI Governance in Japanese Companies
Jun 25, 2025 10:00 JST
Executive Appointments in Connection with the Establishment of NESIC Holdings
Jun 23, 2025 19:22 JST
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis
Jun 23, 2025 13:05 JST
More Latest Release >>